Conclusively, we demonstrate that MTH1 protein targeting using a novel natural small molecular inhibitor, emodin, constitutes a simple and safe anti-cancer therapeutic approach that aims to enhance the deregulated redox metabolism and increase ROS levels in cancer to cause extensive DNA damage specific to cancer cells and therefore leading to senescence. This evidence concerns the gene NUDT1 and cancer.